|1.||Li, Min: 6 articles (09/2015 - 11/2007)|
|2.||Franklin, Renty B: 6 articles (10/2014 - 01/2006)|
|3.||Costello, Leslie C: 5 articles (10/2014 - 01/2006)|
|4.||Chen, Changyi: 5 articles (09/2013 - 11/2007)|
|5.||Zhang, Yuqing: 5 articles (09/2013 - 11/2007)|
|6.||Yao, Qizhi: 5 articles (09/2013 - 11/2007)|
|7.||Taylor, Kathryn M: 5 articles (01/2010 - 12/2004)|
|8.||Cousins, Robert J: 4 articles (11/2015 - 05/2005)|
|9.||Ni, Hong: 4 articles (10/2015 - 02/2009)|
|10.||Zhang, Li: 4 articles (01/2014 - 03/2011)|
|1.||Breast Neoplasms (Breast Cancer)
12/20/2005 - "Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients."
12/01/2014 - "In this article, we describe a novel antibody-drug conjugate (ADC; SGN-LIV1A), targeting the zinc transporter LIV-1 (SLC39A6) for the treatment of metastatic breast cancer. "
05/20/2004 - "Here we identify LIV1, a breast-cancer-associated zinc transporter protein, as a downstream target of STAT3 that is essential and sufficient for STAT3's cell-autonomous role in the EMT of zebrafish gastrula organizer cells. "
01/01/2010 - "We then estimate a gene association network from gene expression data taken from a breast cancer tumor study, showing that scale-free structure prior recovers hubs, including the previously unknown hub SLC39A6, which is a zinc transporter that has been implicated with the spread of breast cancer to the lymph nodes. "
12/01/2008 - "Furthermore, I document a link between another zinc transporter, LIV-1, and breast cancer metastasis, identifying it as a potential new prognostic indicator of breast cancer spread."
|2.||Prostatic Neoplasms (Prostate Cancer)
09/01/2015 - "No zinc transporter variants were associated with prostate cancer risk. "
10/01/2011 - "hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1)."
09/04/2003 - "The gene for the zinc transporter ZnT4 was one of several genes that displayed significantly higher expression in prostate cancer compared to normal tissues from other organs. "
09/04/2003 - "Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer."
01/01/2014 - "Recently, evidence that Zinc transporter ZRT/IRT-like protein 4 (ZIP4) is involved in invasiveness and apoptosis has emerged in pancreatic cancer and prostate cancer. "
06/01/2014 - "Subjects were screened for autoantibodies to GAD (GADA), insulinoma-associated antigen-2 (IA-2A), and zinc-transporter 8 (ZnT8A). "
04/01/2013 - "We consecutively studied 6,156 European diabetic patients attending clinics within 5 years of diagnosis (age range, 30-70 years) examined cross-sectionally clinically and for GAD antibodies (GADA) and antibodies to insulinoma-associated antigen-2 (IA-2A) and zinc-transporter 8 (ZnT8A). "
11/01/2015 - "They underwent prospective monitoring for DSA and beta cell autoantibody (BCAA) levels to GAD65, insulinoma-associated antigen 2 (IA-2), insulin (micro-IAA [mIAA]), and islet-specific zinc transporter isoform-8 (ZnT8). "
01/01/2013 - "Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients."
12/01/2012 - "Dietary zinc reduction, pyruvate supplementation, or zinc transporter 5 knockout attenuates β-cell death in nonobese diabetic mice, islets, and insulinoma cells."
|4.||Glutamate Decarboxylase (Decarboxylase, Glutamate)
|7.||Messenger RNA (mRNA)
|10.||Leukocyte L1 Antigen Complex (Calgranulin)
|1.||Homologous Transplantation (Allograft)